28 students from Egypt, Africa, and the Arab countries have already graduated from the pediatric oncology and radiotherapy fellowship programs, and the ninth cohort is already enrolled.
Starting September, two new sub-specialty programs will be launched in bone marrow transplant and infectious diseases in immunocompromised patients
At 57357, we are committed to continuously seeking education and share it with others, as we believe that spending money on education, training and developing skills is the best investment. In December 2014, we launched the pediatric oncology fellowship training program in collaboration with Dana Farber Boston Children’s cancer and blood disorders Center(DFBC), Harvard University.
The program is implemented under the supervision of experts in pediatric oncology from Egypt and the USA, and aims to create a new generation of qualified cadres capable to be change agents and to contribute to research. According to Dr. Manal Zamzam, head of hospital 57357’s continuous education department, the program started in 2014, and 9 cohorts have been enrolled so far. The number of students currently registered in the program are 41 students, and 27 students, from Kenya, Ethiopia, Kuwait and Sudan have already graduated. Two cohorts have already graduated from the sub-specialty radiotherapy fellowship program.
Training and research
This program is not just a training program, it’s also involving trainees in research work, where the students spend 36 months in training and research, then they present a research project. To obtain the graduation certificate the student should publish his research study in one of the international scientific journals.
The pediatric oncology program aims to develop the skills of pediatricians and radiotherapy doctors and use the principles of modern education to encourage them to do research work. Students enrolled in this program are committed to intensive training and hard work.
New fellowship programs
“We are getting ready to start the bone marrow transplant and the infectious diseases in immunocompromised patients fellowship programs by December 2023, reveals Dr. Zamzam.
Capable of being change agents and innovators
The fellowship program aims to graduate leaders capable of making a difference. Through their training they learn team work skills, to exchange knowledge and expertise, to develop healthcare services and to initiate research ideas, shared the program’s graduated physicians.
57357’s fellowship program partners
Dr. Marl Kiran, Dr. Lesley Lehman, and Dr. Liliana Gominrova from Harvard, the International Cancer Network, USA, and the Association of Friends of the National Cancer-free Initiative, AFNCI.